United States Antithrombotic Drugs Market Report 2017

United States Antithrombotic Drugs Market Report 2017

1 Antithrombotic Drugs Overview

1.1 Product Overview and Scope of Antithrombotic Drugs

1.2 Classification of Antithrombotic Drugs by Product Category

1.2.1 United States Antithrombotic Drugs Market Size (Sales Volume) Comparison by Type (2012-2022)

1.2.2 United States Antithrombotic Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2016

1.2.3 Anticoagulant

1.2.4 Antiplatelet

1.2.5 Thrombolytic Drugs

1.3 United States Antithrombotic Drugs Market by Application/End Users

1.3.1 United States Antithrombotic Drugs Market Size (Consumption) and Market Share Comparison by Application (2012-2022)

1.3.2 Thromboembolic Disease Treatment

1.3.3 Prophylactic Treatment

1.3.4 Blood clot Prevention

1.3.5 Hyperlipidemia Treatment

1.3.6 Others

1.4 United States Antithrombotic Drugs Market by Region

1.4.1 United States Antithrombotic Drugs Market Size (Value) Comparison by Region (2012-2022)

1.4.2 The West Antithrombotic Drugs Status and Prospect (2012-2022)

1.4.3 Southwest Antithrombotic Drugs Status and Prospect (2012-2022)

1.4.4 The Middle Atlantic Antithrombotic Drugs Status and Prospect (2012-2022)

1.4.5 New England Antithrombotic Drugs Status and Prospect (2012-2022)

1.4.6 The South Antithrombotic Drugs Status and Prospect (2012-2022)

1.4.7 The Midwest Antithrombotic Drugs Status and Prospect (2012-2022)

1.5 United States Market Size (Value and Volume) of Antithrombotic Drugs (2012-2022)

1.5.1 United States Antithrombotic Drugs Sales and Growth Rate (2012-2022)

1.5.2 United States Antithrombotic Drugs Revenue and Growth Rate (2012-2022)

2 United States Antithrombotic Drugs Market Competition by Players/Suppliers

2.1 United States Antithrombotic Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)

2.2 United States Antithrombotic Drugs Revenue and Share by Players/Suppliers (2012-2017)

2.3 United States Antithrombotic Drugs Average Price by Players/Suppliers (2012-2017)

2.4 United States Antithrombotic Drugs Market Competitive Situation and Trends

2.4.1 United States Antithrombotic Drugs Market Concentration Rate

2.4.2 United States Antithrombotic Drugs Market Share of Top 3 and Top 5 Players/Suppliers

2.4.3 Mergers & Acquisitions, Expansion in United States Market

2.5 United States Players/Suppliers Antithrombotic Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 United States Antithrombotic Drugs Sales (Volume) and Revenue (Value) by Region (2012-2017)

3.1 United States Antithrombotic Drugs Sales and Market Share by Region (2012-2017)

3.2 United States Antithrombotic Drugs Revenue and Market Share by Region (2012-2017)

3.3 United States Antithrombotic Drugs Price by Region (2012-2017)

4 United States Antithrombotic Drugs Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)

4.1 United States Antithrombotic Drugs Sales and Market Share by Type (Product Category) (2012-2017)

4.2 United States Antithrombotic Drugs Revenue and Market Share by Type (2012-2017)

4.3 United States Antithrombotic Drugs Price by Type (2012-2017)

4.4 United States Antithrombotic Drugs Sales Growth Rate by Type (2012-2017)

5 United States Antithrombotic Drugs Sales (Volume) by Application (2012-2017)

5.1 United States Antithrombotic Drugs Sales and Market Share by Application (2012-2017)

5.2 United States Antithrombotic Drugs Sales Growth Rate by Application (2012-2017)

5.3 Market Drivers and Opportunities

6 United States Antithrombotic Drugs Players/Suppliers Profiles and Sales Data

6.1 Sanofi

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Antithrombotic Drugs Product Category, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 Sanofi Antithrombotic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.1.4 Main Business/Business Overview

6.2 Bayer

6.2.2 Antithrombotic Drugs Product Category, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 Bayer Antithrombotic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.2.4 Main Business/Business Overview

6.3 Boehringer Ingelheim

6.3.2 Antithrombotic Drugs Product Category, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 Boehringer Ingelheim Antithrombotic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.3.4 Main Business/Business Overview

6.4 Genentech

6.4.2 Antithrombotic Drugs Product Category, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 Genentech Antithrombotic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.4.4 Main Business/Business Overview

6.5 Eli Lilly

6.5.2 Antithrombotic Drugs Product Category, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 Eli Lilly Antithrombotic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.5.4 Main Business/Business Overview

6.6 Johnson & Johnson

6.6.2 Antithrombotic Drugs Product Category, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 Johnson & Johnson Antithrombotic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.6.4 Main Business/Business Overview

6.7 Medicines Company

6.7.2 Antithrombotic Drugs Product Category, Application and Specification

6.7.2.1 Product A

6.7.2.2 Product B

6.7.3 Medicines Company Antithrombotic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.7.4 Main Business/Business Overview

6.8 Pfizer

6.8.2 Antithrombotic Drugs Product Category, Application and Specification

6.8.2.1 Product A

6.8.2.2 Product B

6.8.3 Pfizer Antithrombotic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.8.4 Main Business/Business Overview

6.9 Otsuka

6.9.2 Antithrombotic Drugs Product Category, Application and Specification

6.9.2.1 Product A

6.9.2.2 Product B

6.9.3 Otsuka Antithrombotic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.9.4 Main Business/Business Overview

6.10 Reddy’s Laboratories

6.10.2 Antithrombotic Drugs Product Category, Application and Specification

6.10.2.1 Product A

6.10.2.2 Product B

6.10.3 Reddy’s Laboratories Antithrombotic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.10.4 Main Business/Business Overview

7 Antithrombotic Drugs Manufacturing Cost Analysis

7.1 Antithrombotic Drugs Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Antithrombotic Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Antithrombotic Drugs Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Antithrombotic Drugs Major Manufacturers in 2016

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 United States Antithrombotic Drugs Market Size (Value and Volume) Forecast (2017-2022)

11.1 United States Antithrombotic Drugs Sales Volume, Revenue Forecast (2017-2022)

11.2 United States Antithrombotic Drugs Sales Volume Forecast by Type (2017-2022)

11.3 United States Antithrombotic Drugs Sales Volume Forecast by Application (2017-2022)

11.4 United States Antithrombotic Drugs Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

Figure Product Picture of Antithrombotic Drugs

Figure United States Antithrombotic Drugs Market Size (K Doses) by Type (2012-2022)

Figure United States Antithrombotic Drugs Sales Volume Market Share by Type (Product Category) in 2016

Figure Anticoagulant Product Picture

Figure Antiplatelet Product Picture

Figure Thrombolytic Drugs Product Picture

Figure United States Antithrombotic Drugs Market Size (K Doses) by Application (2012-2022)

Figure United States Sales Market Share of Antithrombotic Drugs by Application in 2016

Figure Thromboembolic Disease Treatment Examples

Figure Prophylactic Treatment Examples

Figure Blood clot Prevention Examples

Figure Hyperlipidemia Treatment Examples

Figure Others Examples

Figure United States Antithrombotic Drugs Market Size (Value) by Region (2012-2022)

Figure The West Antithrombotic Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure Southwest Antithrombotic Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Middle Atlantic Antithrombotic Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure New England Antithrombotic Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure The South of US Antithrombotic Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Midwest Antithrombotic Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Antithrombotic Drugs Sales (K Doses) and Growth Rate (2012-2022)

Figure United States Antithrombotic Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Antithrombotic Drugs Market Major Players Product Sales Volume (2012-2017)

Table United States Antithrombotic Drugs Sales (K Doses) of Key Players/Suppliers (2012-2017)

Table United States Antithrombotic Drugs Sales Share by Players/Suppliers (2012-2017)

Figure 2016 United States Antithrombotic Drugs Sales Share by Players/Suppliers

Figure 2017 United States Antithrombotic Drugs Sales Share by Players/Suppliers

Figure United States Antithrombotic Drugs Market Major Players Product Revenue (Million USD) (2012-2017)

Table United States Antithrombotic Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)

Table United States Antithrombotic Drugs Revenue Share by Players/Suppliers (2012-2017)

Figure 2016 United States Antithrombotic Drugs Revenue Share by Players/Suppliers

Figure 2017 United States Antithrombotic Drugs Revenue Share by Players/Suppliers

Table United States Market Antithrombotic Drugs Average Price (USD/Dose) of Key Players/Suppliers (2012-2017)

Figure United States Market Antithrombotic Drugs Average Price of Key Players/Suppliers in 2016

Figure United States Antithrombotic Drugs Market Share of Top 3 Players/Suppliers

Figure United States Antithrombotic Drugs Market Share of Top 5 Players/Suppliers

Table United States Players/Suppliers Antithrombotic Drugs Manufacturing Base Distribution and Sales Area

Table United States Players/Suppliers Antithrombotic Drugs Product Category

Table United States Antithrombotic Drugs Sales (K Doses) by Region (2012-2017)

Table United States Antithrombotic Drugs Sales Share by Region (2012-2017)

Figure United States Antithrombotic Drugs Sales Share by Region (2012-2017)

Figure United States Antithrombotic Drugs Sales Market Share by Region in 2016

Table United States Antithrombotic Drugs Revenue (Million USD) and Market Share by Region (2012-2017)

Table United States Antithrombotic Drugs Revenue Share by Region (2012-2017)

Figure United States Antithrombotic Drugs Revenue Market Share by Region (2012-2017)

Figure United States Antithrombotic Drugs Revenue Market Share by Region in 2016

Table United States Antithrombotic Drugs Price (USD/Dose) by Region (2012-2017)

Table United States Antithrombotic Drugs Sales (K Doses) by Type (2012-2017)

Table United States Antithrombotic Drugs Sales Share by Type (2012-2017)

Figure United States Antithrombotic Drugs Sales Share by Type (2012-2017)

Figure United States Antithrombotic Drugs Sales Market Share by Type in 2016

Table United States Antithrombotic Drugs Revenue (Million USD) and Market Share by Type (2012-2017)

Table United States Antithrombotic Drugs Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Antithrombotic Drugs by Type (2012-2017)

Figure Revenue Market Share of Antithrombotic Drugs by Type in 2016

Table United States Antithrombotic Drugs Price (USD/Dose) by Types (2012-2017)

Figure United States Antithrombotic Drugs Sales Growth Rate by Type (2012-2017)

Table United States Antithrombotic Drugs Sales (K Doses) by Application (2012-2017)

Table United States Antithrombotic Drugs Sales Market Share by Application (2012-2017)

Figure United States Antithrombotic Drugs Sales Market Share by Application (2012-2017)

Figure United States Antithrombotic Drugs Sales Market Share by Application in 2016

Table United States Antithrombotic Drugs Sales Growth Rate by Application (2012-2017)

Figure United States Antithrombotic Drugs Sales Growth Rate by Application (2012-2017)

Table Sanofi Basic Information List

Table Sanofi Antithrombotic Drugs Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)

Figure Sanofi Antithrombotic Drugs Sales Growth Rate (2012-2017)

Figure Sanofi Antithrombotic Drugs Sales Market Share in United States (2012-2017)

Figure Sanofi Antithrombotic Drugs Revenue Market Share in United States (2012-2017)

Table Bayer Basic Information List

Table Bayer Antithrombotic Drugs Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)

Figure Bayer Antithrombotic Drugs Sales Growth Rate (2012-2017)

Figure Bayer Antithrombotic Drugs Sales Market Share in United States (2012-2017)

Figure Bayer Antithrombotic Drugs Revenue Market Share in United States (2012-2017)

Table Boehringer Ingelheim Basic Information List

Table Boehringer Ingelheim Antithrombotic Drugs Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)

Figure Boehringer Ingelheim Antithrombotic Drugs Sales Growth Rate (2012-2017)

Figure Boehringer Ingelheim Antithrombotic Drugs Sales Market Share in United States (2012-2017)

Figure Boehringer Ingelheim Antithrombotic Drugs Revenue Market Share in United States (2012-2017)

Table Genentech Basic Information List

Table Genentech Antithrombotic Drugs Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)

Figure Genentech Antithrombotic Drugs Sales Growth Rate (2012-2017)

Figure Genentech Antithrombotic Drugs Sales Market Share in United States (2012-2017)

Figure Genentech Antithrombotic Drugs Revenue Market Share in United States (2012-2017)

Table Eli Lilly Basic Information List

Table Eli Lilly Antithrombotic Drugs Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)

Figure Eli Lilly Antithrombotic Drugs Sales Growth Rate (2012-2017)

Figure Eli Lilly Antithrombotic Drugs Sales Market Share in United States (2012-2017)

Figure Eli Lilly Antithrombotic Drugs Revenue Market Share in United States (2012-2017)

Table Johnson & Johnson Basic Information List

Table Johnson & Johnson Antithrombotic Drugs Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)

Figure Johnson & Johnson Antithrombotic Drugs Sales Growth Rate (2012-2017)

Figure Johnson & Johnson Antithrombotic Drugs Sales Market Share in United States (2012-2017)

Figure Johnson & Johnson Antithrombotic Drugs Revenue Market Share in United States (2012-2017)

Table Medicines Company Basic Information List

Table Medicines Company Antithrombotic Drugs Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)

Figure Medicines Company Antithrombotic Drugs Sales Growth Rate (2012-2017)

Figure Medicines Company Antithrombotic Drugs Sales Market Share in United States (2012-2017)

Figure Medicines Company Antithrombotic Drugs Revenue Market Share in United States (2012-2017)

Table Pfizer Basic Information List

Table Pfizer Antithrombotic Drugs Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)

Figure Pfizer Antithrombotic Drugs Sales Growth Rate (2012-2017)

Figure Pfizer Antithrombotic Drugs Sales Market Share in United States (2012-2017)

Figure Pfizer Antithrombotic Drugs Revenue Market Share in United States (2012-2017)

Table Otsuka Basic Information List

Table Otsuka Antithrombotic Drugs Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)

Figure Otsuka Antithrombotic Drugs Sales Growth Rate (2012-2017)

Figure Otsuka Antithrombotic Drugs Sales Market Share in United States (2012-2017)

Figure Otsuka Antithrombotic Drugs Revenue Market Share in United States (2012-2017)

Table Reddy’s Laboratories Basic Information List

Table Reddy’s Laboratories Antithrombotic Drugs Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)

Figure Reddy’s Laboratories Antithrombotic Drugs Sales Growth Rate (2012-2017)

Figure Reddy’s Laboratories Antithrombotic Drugs Sales Market Share in United States (2012-2017)

Figure Reddy’s Laboratories Antithrombotic Drugs Revenue Market Share in United States (2012-2017)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Antithrombotic Drugs

Figure Manufacturing Process Analysis of Antithrombotic Drugs

Figure Antithrombotic Drugs Industrial Chain Analysis

Table Raw Materials Sources of Antithrombotic Drugs Major Players/Suppliers in 2016

Table Major Buyers of Antithrombotic Drugs

Table Distributors/Traders List

Figure United States Antithrombotic Drugs Sales Volume (K Doses) and Growth Rate Forecast (2017-2022)

Figure United States Antithrombotic Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure United States Antithrombotic Drugs Price (USD/Dose) Trend Forecast (2017-2022)

Table United States Antithrombotic Drugs Sales Volume (K Doses) Forecast by Type (2017-2022)

Figure United States Antithrombotic Drugs Sales Volume (K Doses) Forecast by Type (2017-2022)

Figure United States Antithrombotic Drugs Sales Volume (K Doses) Forecast by Type in 2022

Table United States Antithrombotic Drugs Sales Volume (K Doses) Forecast by Application (2017-2022)

Figure United States Antithrombotic Drugs Sales Volume (K Doses) Forecast by Application (2017-2022)

Figure United States Antithrombotic Drugs Sales Volume (K Doses) Forecast by Application in 2022

Table United States Antithrombotic Drugs Sales Volume (K Doses) Forecast by Region (2017-2022)

Table United States Antithrombotic Drugs Sales Volume Share Forecast by Region (2017-2022)

Figure United States Antithrombotic Drugs Sales Volume Share Forecast by Region (2017-2022)

Figure United States Antithrombotic Drugs Sales Volume Share Forecast by Region in 2022

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources